Targeting Glycans and Heavily Glycosylated Proteins for Tumor Imaging. (2020)
Attributed to:
Improving the functional affinity of human anti-glycan monoclonal antibodies (mabs) for cancer therapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers12123870
PubMed Identifier: 33371487
Publication URI: http://europepmc.org/abstract/MED/33371487
Type: Journal Article/Review
Volume: 12
Parent Publication: Cancers
Issue: 12
ISSN: 2072-6694